Special Issue "Role of microRNA in Neuroendocrine Neoplasms"
A special issue of Non-Coding RNA (ISSN 2311-553X).
Deadline for manuscript submissions: 30 June 2022 | Viewed by 6432
Special Issue Editor

Interests: microRNA; non-coding RNA; RNA detection and analysis; molecular mechanisms; pathology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuroendocrine neoplasms are highly heterogeneous tumors that are incompletely understood at the molecular level. Diagnosis is frequently delayed, pathologic classification can be challenging, and many patients develop non-curable metastatic disease. microRNAs (miRNAs) are small RNA regulatory molecules that negatively regulate gene expression. These molecules are often dysregulated in tumorigenic processes and can also be used as disease biomarkers. Over the past decade, it has become increasingly clear that miRNAs mediate multiple aspects of neuroendocrine neoplasia and have clinical diagnostic utility. In this Special Issue, we focus on clinical, biological, and computational studies of miRNA-mediated gene regulation and dysregulation in all NENs (including lung carcinoids, small cell lung carcinoma, gastroenteropancreatic NENs, Merkel cell carcinoma, medullary thyroid cancer, pituitary adenoma, neuroblastoma, paraganglioma, pheochromocytoma, etc.). A full understanding of miRNA changes in these diverse neoplasms will advance our knowledge of NEN biology and pave the way for novel diagnostic, prognostic, predictive, and therapeutic approaches.
We look forward to receiving your contribution to this Special Issue.
Dr. Neil Renwick
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Non-Coding RNA is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine neoplasms
- microRNA
- microRNA-mediated gene regulation
- microRNA-guided diagnostics
- microRNA pathomechanisms
- microRNA therapeutics
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: miRNA-mRNA target interactions in lung neuroendocrine tumor cell lines
Authors: Neil Renwick
Affiliation: Laboratory of Translational RNA Biology; Department of Pathology and Molecular Medicine; Queen's University
Abstract: none
Title: (tentative): microRNA expression signature of ovarian pulmonary-type small cell carcinoma reveals similarities with small cell carcinoma of the lung. A peculiar case with a systematic review of the literature.
Authors: Anna Myriam Perrone1,2, Lorena Marchio3, Giulia Girolimetti3, Stefano Miglietta4, Anna Ghelli4, Noemi Laprovitera5, Antonio De Leo5, Dario De Biase5, Pierandrea De Iaco1,2, Manuela Ferracin5, Anna Mar
Affiliation: 1. Gynecology Oncology Unit, Dept. of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy 2. IRCCS , Bologna, Italy 3. Unit of Medical Genetics, Dept. of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy 4. Dept. of Pharmacy and Biotechnology (FABIT), University of Bologna, Italy 5. Dept. of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy
Abstract: none